Real-Time Genome Sequencing Helps Control Hospital Outbreak
By LabMedica International staff writers Posted on 01 Dec 2014 |
Whole-genome sequencing (WGS) of bacterial isolates provides a promising contemporary method for investigating the epidemiology of outbreaks, particularly when coupled to clinical locational and temporal data.
Acinetobacter baumannii is an important cause of nosocomial or hospital-acquired infection, particularly ventilator-associated pneumonia and bloodstream infections in critically ill patients, and has a tendency to cause hospital outbreaks.
Scientists at the Warwick Medical School (UK) and their colleagues investigated multidrug-resistant Acinetobacter (MDR-Aci) isolates obtained from routine clinical samples through culture on blood agar, followed by single-colony isolation. Bacterial identification and antibiotic susceptibility testing were performed in the hospital microbiology laboratory on the Vitek 2 system (bioMérieux; Basingstoke, UK). Multidrug resistance was defined as resistance to equal to or greater than three classes of antibiotics; quinolones, extended-spectrum cephalosporins, β-lactam/β-lactamase inhibitor combinations, aminoglycosides, and carbapenems.
Genomic DNA was extracted from 114 putative Acinetobacter isolates, applying Qiagen 100/G Genomic-tips (Manchester, UK ) to 5 mL to 10 mL of overnight culture. The genome of an isolate from a patient was sequenced on two different sequencing platforms, the 454 FLX (454 Life Sciences, Branford, CT, USA) and the Illumina MiSeq (San Diego, CA, USA). The scientists were able to identify 74 patients belonging to a prolonged outbreak in the hospital by sampling both patients and the environment. They then determined the detailed genetic makeup of the bacteria carried by each of these patients and used this data, with information about the ward that the patients were housed in, and the date of their first positive tests, to identify nearly 70 possible transmission events. Armed with this detailed information, the investigators were able to pinpoint transmission hot spots within the hospital, which included an operating theatre and a specialized bed for burns patients. Deep cleaning of these transmission sites followed and new decontamination protocols were put in place by the hospital.
The authors concluded that whole genome sequencing is now poised to make an impact on hospital infection prevention and control, delivering cost-effective identification of routes of infection within a clinically relevant timeframe and allowing infection control teams to track, and even prevent, the spread of drug-resistant hospital pathogens. Mark J. Pallen, MD, PhD, the senior author of the study, said, “We have demonstrated how whole genome sequencing can be applied in a clinically helpful timeframe to track and control the spread of drug-resistant hospital pathogens. In this case, it helped understand and control what was probably longest running A. baumannii outbreak ever seen in this country.” The study was published on November 20, 2014, in the journal Genome Medicine.
Related Links:
Warwick Medical School
bioMérieux
454 Life Sciences
Acinetobacter baumannii is an important cause of nosocomial or hospital-acquired infection, particularly ventilator-associated pneumonia and bloodstream infections in critically ill patients, and has a tendency to cause hospital outbreaks.
Scientists at the Warwick Medical School (UK) and their colleagues investigated multidrug-resistant Acinetobacter (MDR-Aci) isolates obtained from routine clinical samples through culture on blood agar, followed by single-colony isolation. Bacterial identification and antibiotic susceptibility testing were performed in the hospital microbiology laboratory on the Vitek 2 system (bioMérieux; Basingstoke, UK). Multidrug resistance was defined as resistance to equal to or greater than three classes of antibiotics; quinolones, extended-spectrum cephalosporins, β-lactam/β-lactamase inhibitor combinations, aminoglycosides, and carbapenems.
Genomic DNA was extracted from 114 putative Acinetobacter isolates, applying Qiagen 100/G Genomic-tips (Manchester, UK ) to 5 mL to 10 mL of overnight culture. The genome of an isolate from a patient was sequenced on two different sequencing platforms, the 454 FLX (454 Life Sciences, Branford, CT, USA) and the Illumina MiSeq (San Diego, CA, USA). The scientists were able to identify 74 patients belonging to a prolonged outbreak in the hospital by sampling both patients and the environment. They then determined the detailed genetic makeup of the bacteria carried by each of these patients and used this data, with information about the ward that the patients were housed in, and the date of their first positive tests, to identify nearly 70 possible transmission events. Armed with this detailed information, the investigators were able to pinpoint transmission hot spots within the hospital, which included an operating theatre and a specialized bed for burns patients. Deep cleaning of these transmission sites followed and new decontamination protocols were put in place by the hospital.
The authors concluded that whole genome sequencing is now poised to make an impact on hospital infection prevention and control, delivering cost-effective identification of routes of infection within a clinically relevant timeframe and allowing infection control teams to track, and even prevent, the spread of drug-resistant hospital pathogens. Mark J. Pallen, MD, PhD, the senior author of the study, said, “We have demonstrated how whole genome sequencing can be applied in a clinically helpful timeframe to track and control the spread of drug-resistant hospital pathogens. In this case, it helped understand and control what was probably longest running A. baumannii outbreak ever seen in this country.” The study was published on November 20, 2014, in the journal Genome Medicine.
Related Links:
Warwick Medical School
bioMérieux
454 Life Sciences
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia